Literature DB >> 10432298

Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.

I Murray1, J Köhl, K Cianflone.   

Abstract

Acylation-stimulating protein (ASP or C3adesArg) is a potent lipogenic factor in human and murine adipocytes and fibroblasts. The arginated form of ASP, i.e. complement C3a (C3a), stimulates immunological responses in human granulocytes, mast cells, guinea pig platelets and guinea pig macrophages; however, ASP is inactive in stimulating these responses. Thus both ASP and C3a are bioactive across species but are not functionally interchangeable. Tertiary structure of both proteins by X-ray crystallography and NMR spectroscopy predicts a tightly linked core region consisting of three alpha-helices linked via three disulphide bonds, with one of the alpha-helices extending out from the core and terminating in a flexible conformationally irregular carboxy-tail region. The present studies were undertaken in order to define the functionally active domains of ASP, distinctive from those of C3a, using chemical modifications, enzymic cleavage and synthetic peptide fragments. The results indicate that: (i) the N-terminal region (<10 amino acids) plays little role in ASP receptor binding and triacylglycerol synthesis stimulation; (ii) the native C-terminal region had no activity, but modifications which increased hydrophobicity increased receptor binding, and led to some activation of triacylglycerol synthesis stimulation; (iii) an intact disulphide-linked core region is essential for triacylglycerol synthesis stimulation activity but not for receptor interaction. Finally, basic charges in the carboxy region (His) are essential for ASP triacylglycerol synthesis stimulation but not for receptor binding, whereas both functions are eliminated by the modification of Lys in the disulphide-linked core region. The present results suggest that there are two functional domains in ASP, one that is responsible for the initial binding to the cell surface receptor, and a second domain that activates and increases triacylglycerol synthesis stimulation. This contrasts markedly with the structure-function studies of C3a where both binding competency and function were dependent on the C-terminal Arg. Thus ASP demonstrates distinct bioactivity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432298      PMCID: PMC1220434     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

1.  Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study.

Authors:  M Federwisch; M Casaretto; R Gerardy-Schahn; D Bitter-Suermann; A Wollmer
Journal:  Biophys Chem       Date:  1992-10       Impact factor: 2.352

2.  Synthetic peptides as antagonists of the anaphylatoxin C3a.

Authors:  T Kretzschmar; M Pohl; M Casaretto; M Przewosny; W Bautsch; A Klos; D Saunders; J Köhl
Journal:  Eur J Biochem       Date:  1992-11-15

Review 3.  Cellular and molecular aspects of adipose tissue development.

Authors:  G Ailhaud; P Grimaldi; R Négrel
Journal:  Annu Rev Nutr       Date:  1992       Impact factor: 11.848

4.  Complete complementary DNA sequence of the third component of complement of lamprey. Implication for the evolution of thioester containing proteins.

Authors:  M Nonaka; M Takahashi
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

5.  C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding.

Authors:  A Klos; S Bank; C Gietz; W Bautsch; J Köhl; M Burg; T Kretzschmar
Journal:  Biochemistry       Date:  1992-11-24       Impact factor: 3.162

6.  Phylogeny of the third component of complement, C3: analysis of the conservation of human CR1, CR2, H, and B binding sites, concanavalin A binding sites, and thiolester bond in the C3 from different species.

Authors:  J Alsenz; D Avila; H P Huemer; I Esparza; J D Becherer; T Kinoshita; Y Wang; S Oppermann; J D Lambris
Journal:  Dev Comp Immunol       Date:  1992 Jan-Feb       Impact factor: 3.636

7.  Proton nuclear magnetic resonance study of the third component of complement: solution conformation of the carboxyl-terminal segment of C3a fragment.

Authors:  Y Muto; Y Fukumoto; Y Arata
Journal:  Biochemistry       Date:  1985-11-05       Impact factor: 3.162

8.  The role of lysine, histidine and carboxyl residues in biological activity of equinatoxin II, a pore forming polypeptide from the sea anemone Actinia equina L.

Authors:  T Turk; P Macek
Journal:  Biochim Biophys Acta       Date:  1992-02-13

9.  Primary structure of cobra complement component C3.

Authors:  D C Fritzinger; E C Petrella; M B Connelly; R Bredehorst; C W Vogel
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

10.  Chronic myelogenous leukemia-derived basophilic granulocytes express a functional active receptor for the anaphylatoxin C3a.

Authors:  T Kretzschmar; A Jeromin; C Gietz; W Bautsch; A Klos; J Köhl; G Rechkemmer; D Bitter-Suermann
Journal:  Eur J Immunol       Date:  1993-02       Impact factor: 5.532

View more
  6 in total

Review 1.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 2.  Lipoprotein disorders and cardiovascular risk.

Authors:  J Genest
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

3.  Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms.

Authors:  Mercedes Nancy Munkonda; Marc Lapointe; Pierre Miegueu; Christian Roy; Danny Gauvreau; Denis Richard; Katherine Cianflone
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

4.  Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.

Authors:  Georgios S Papaetis; Panagiotis Papakyriakou; Themistoklis N Panagiotou
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

5.  Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial.

Authors:  Michele Hepponstall; Vera Ignjatovic; Steve Binos; Chantal Attard; Vasiliki Karlaftis; Yves d'Udekem; Paul Monagle; Igor E Konstantinov
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

6.  The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.

Authors:  Cheryl Cero; Maria Razzoli; Ruijun Han; Bhavani Shankar Sahu; Jessica Patricelli; ZengKui Guo; Nathan A Zaidman; John M Miles; Scott M O'Grady; Alessandro Bartolomucci
Journal:  Mol Metab       Date:  2016-10-31       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.